Aberrant CXCR4/CXCL12 signaling is associated with a variety of pathophysiological conditions including cancer metastasis, enhanced tumor growth, chronic inflammation, leukemia and altered immune responses [2,3]. Here, CXCR4 is linked to neoplasm.